F9 and hemophilia: Our study analyzed the demographics, clinical manifestations, diagnostic and treatment characteristics, inhibitor incidence, genotype, joint status and QoL of patients with HB in the central and western regions of China, as well as F9 gene and factor activity levels of their mothers, to provide a basis for hemophilia management.